101 related articles for article (PubMed ID: 6738937)
1. Effects of prostaglandin E2 analogue suppository on blood loss in suction abortion.
Sidhu MS; Kent DR
Obstet Gynecol; 1984 Jul; 64(1):128-30. PubMed ID: 6738937
[TBL] [Abstract][Full Text] [Related]
2. Preabortion cervical dilatation with a low-dose prostaglandin suppository. A comparison of two analogs.
Lauersen NH; Graves ZR
J Reprod Med; 1984 Feb; 29(2):133-5. PubMed ID: 6708030
[TBL] [Abstract][Full Text] [Related]
3. [Preoperative dilatation of the cervix uteri by vaginal application of 9-deoxo-16, 16-dimethyl-9-methylene PGE2 in pregnancy interruption during the 1st trimester. Double-blind clinical study].
Friedli A; De Grandi P
J Gynecol Obstet Biol Reprod (Paris); 1986; 15(2):215-21. PubMed ID: 3522723
[TBL] [Abstract][Full Text] [Related]
4. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
Bygdeman M; Christensen N; Gréen K; Lundström V
Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
[TBL] [Abstract][Full Text] [Related]
5. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
Borten M; DiLeo LA; Friedman EA
Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
[TBL] [Abstract][Full Text] [Related]
6. Intravaginal administration of 9-deoxo-9-methylene-16,16-dimethyl PGE2 for cervical dilation prior to suction curettage.
Shapiro AG; Lasseter K; Cobiella A; Domenzain M
Int J Gynaecol Obstet; 1982 Apr; 20(2):137-40. PubMed ID: 6125434
[TBL] [Abstract][Full Text] [Related]
7. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
Brenner PF; Marrs RP; Roy S; Mishell DR
Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197
[TBL] [Abstract][Full Text] [Related]
8. [Preoperative cervix dilatation in 1st trimester pregnancy interruption using 9-deoxy-16, 16-dimethyl-9-methylene prostaglandin E2. A randomized double-blind study].
Brügger D; Dreher E
Geburtshilfe Frauenheilkd; 1985 Aug; 45(8):567-9. PubMed ID: 4043711
[TBL] [Abstract][Full Text] [Related]
9. [Cervical dilatation by use of a vaginal suppository of meteneprost before voluntary interruption of the pregnancy in the first trimester].
Maria B; André-David F; Oury JF; Stampf F; Bresson E; Rosenberg P
J Gynecol Obstet Biol Reprod (Paris); 1987; 16(5):637-42. PubMed ID: 3668189
[TBL] [Abstract][Full Text] [Related]
10. Cervical dilatation with meteneprost vaginal suppositories in first trimester abortion.
Somell C; Olund A
Contraception; 1986 Feb; 33(2):189-94. PubMed ID: 3698595
[TBL] [Abstract][Full Text] [Related]
11. Cervical dilatation in the nonpregnant patient with vaginal 16-dimethyl prostaglandin E2.
Nuss RC; Baird T; Benrubi G; Thompson RJ
J Fla Med Assoc; 1985 Jun; 72(6):426-7. PubMed ID: 4045400
[No Abstract] [Full Text] [Related]
12. Pre-abortion treatment with a single vaginal suppository containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 in late first and early second trimester pregnancies.
Moberg PJ; Bygdeman M; Carnsjö LG; Frankman O; Gréen K
Acta Obstet Gynecol Scand Suppl; 1983; 113():137-40. PubMed ID: 6574668
[TBL] [Abstract][Full Text] [Related]
13. [Development of a long-acting vaginal suppository for termination of 2d trimester pregnancy and for preoperative cervical dilatation].
Bygdeman M; Gréen K; Lundström V
Lakartidningen; 1977 Nov; 74(46):4107-9. PubMed ID: 926943
[No Abstract] [Full Text] [Related]
14. Preoperative cervical dilatation with a single long-acting prostaglandin analog suppository. An alternative to traumatic mechanical dilatation before surgical evacuation.
Kent DR; Goldstein AI; Milokovich D
J Reprod Med; 1983 Nov; 28(11):778-80. PubMed ID: 6655636
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin vaginal suppositories in non pregnant women requiring cervical dilatation prior to hysteroscopy.
Hald F; Kristoffersen SE; Gregersen E
Acta Obstet Gynecol Scand; 1988; 67(3):219-22. PubMed ID: 3051874
[TBL] [Abstract][Full Text] [Related]
16. Development of a vaginal gel containing 9-deoxo-16,16-dimethyl-9-methylene PGE2 for cervical dilatation and pregnancy termination.
Gréen K; Bygdeman M; Swahn ML; Vesterqvist O; Christensen NJ
Prostaglandins Leukot Essent Fatty Acids; 1988 Aug; 33(2):121-7. PubMed ID: 3174718
[TBL] [Abstract][Full Text] [Related]
17. The use of 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) vaginal suppositories for the termination of early pregnancy. A comparative study.
Smith SK; Baird DT
Br J Obstet Gynaecol; 1980 Aug; 87(8):712-7. PubMed ID: 7426533
[TBL] [Abstract][Full Text] [Related]
18. Cervical dilation before first-trimester elective abortion: a controlled comparison of meteneprost, laminaria, and hypan.
Darney PD; Dorward K
Obstet Gynecol; 1987 Sep; 70(3 Pt 1):397-400. PubMed ID: 3627588
[TBL] [Abstract][Full Text] [Related]
19. Study of 16,16'-dimethyl-trans-delta 2 prostaglandin E1 methyl ester vaginal suppository for cervical dilatation in premenopausal and postmenopausal women.
Rabe T; Willinger G; Kiesel L; Runnebaum B; Kubili F; Mösche R; Nobakht N
Adv Contracept; 1985 Mar; 1(1):91-102. PubMed ID: 3916041
[TBL] [Abstract][Full Text] [Related]
20. Self-administration of prostaglandin for termination of early pregnancy.
Bygdeman M; Christensen NJ; Gréen K; Zheng S
Contraception; 1981 Jul; 24(1):45-52. PubMed ID: 7023823
[No Abstract] [Full Text] [Related]
[Next] [New Search]
